https://doi.org/10.4081/reumatismo.2013.4

Italian Society of Rheumatology recommendations for the management of gout

Vol. 65 No. 1 (2013)
Submitted: 24 February 2013
Accepted: 27 February 2013
Published: 28 March 2013
Gout, treatment, recommendations.
Abstract Views: 5538
PDF: 1491
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

M. Manara
maria.manara@gmail.com
Epidemiology Unit, Italian Society of Rheumatology (SIR), Milano, Italy.
A. Bortoluzzi
Rheumatology Unit, Department of Clinical and Experimental Medicine, Ferrara University, Italy.
M. Favero
Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy.
I. Prevete
Rheumatology Unit, S. Camillo Hospital, Roma, Italy.
C.A. Scirè
Epidemiology Unit, Italian Society of Rheumatology (SIR), Milano, Italy.
G. Bianchi
Rheumatology Unit, Azienda Sanitaria Locale 3, Genova, Italy.
C. Borghi
Department of Internal Medicine, University of Bologna, Bologna, Italian Society for Cardiovascular Disease Prevention (SIPREC), Italy.
M. A. Cimmino
Rheumatology Clinic, Department of Internal Medicine, University of Genova, Genova, Italy.
G. M. D'Avola
Rheumatology and Osteoporosis Service, ASP 3, Catania, Italy.
G. Desideri
Geriatric Unit, Department of Life, Health, and Environmental Sciences, University of L’Aquila, L’Aquila, Italy; Italian Society of Gerontology and Geriatrics (SIGG), Italy.
G. Di Giacinto
General practitioner, ASUR Marche, Urbino, Italy; Italian Interdisciplinary Society for Primary Care (SIICP), Italy.
M. Govoni
Rheumatology Unit, Department of Clinical and Experimental Medicine, Ferrara University, St. Anna University Hospital, Ferrara, Italy.
W. Grassi
Rheumatology Clinic, Università Politecnica delle Marche, Jesi, Ancona, Italy.
A. Lombardi
General practitioner, ASL 10 Firenze, Italy; METIS Scientific Association of Italian Family Doctors, Italy.
M. Marangella
Nephrology Unit, Mauriziano Hospital, Torino; Italian Society of Nephrology (SIN), Italy.
M. Matucci Cerinic
Department of Biomedicine, Division of Rheumatology A.O.U.C., Department of Medicine, Denothe Centre, University of Florence, Florence, Italy.
G. Medea
General practitioner, Brescia, Italy; Italian Society of General Medicine (SIMG), Italy.
R. Ramonda
Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy.
A. Spadaro
Clinical and Medical Therapy Department, Rheumatology Unit, La Sapienza University, Rome, Italy.
L. Punzi
Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, .
G. Minisola
Rheumatology Unit, S. Camillo Hospital, Roma, Italy.
Objective: Gout is the most common arthritis in adults. Despite the availability of valid therapeutic options, the management of patients with gout is still suboptimal. The Italian Society of Rheumatology (SIR) aimed to update, adapt to national contest and disseminate the 2006 EULAR recommendations for the management of gout.
Methods: The multidisciplinary group of experts included rheumatologists, general practitioners, internists, geriatricians, nephrologists, cardiologists and evidence-based medicine experts. To maintain consistency with EULAR recommendations, a similar methodology was utilized by the Italian group. The original propositions were translated in Italian and priority research queries were identified through a Delphi consensus approach. A systematic search was conducted for selected queries. Efficacy and safety data on drugs reported in RCTs were combined in a meta-analysis where feasible. The strength of recommendation was measured by utilising the EULAR ordinal and visual analogue scales.
Results: The original 12 propositions were translated and adapted to Italian context. Further evidences were collected about the role of diet in the non-pharmacological treatment of gout and the efficacy of oral corticosteroids and low-dose colchicine in the management of acute attacks. Statements concerning uricosuric treatments were withdrawn and replaced with a proposition focused on a new urate lowering agent, febuxostat. A research agenda was developed to identify topics still not adequately investigated concerning the management of gout.
Conclusions: The SIR has developed updated recommendations for the management of gout adapted to the Italian healthcare system. Their implementation in clinical practice is expected to improve the management of patients with gout.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Manara, M., Bortoluzzi, A., Favero, M., Prevete, I., Scirè, C., Bianchi, G., … Minisola, G. (2013). Italian Society of Rheumatology recommendations for the management of gout. Reumatismo, 65(1), 4–21. https://doi.org/10.4081/reumatismo.2013.4

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.